Home >  Blog >  AVATAR Evidencia Actualizada 2016

AVATAR Evidencia Actualizada 2016

Posted on 9 November 2016

1. Ofrezca aerosol refrigerante para reducir el dolor de inserción de la vía venosa periférica (VVP).

2. Use 1-2 gotas de adhesivo tisular en el sitio de inserción de la VVP, centro y alas. Aplique el apósito.

3. Revise periódicamente la VVP. Mantener la VVP > 3 días si es necesario y si no presenta complicaciones.

4. Prepare la piel con clorhexidina al 2% en alcohol para la inserción de catéter arterial, diálisis y central.

5. Utilice un disco/apósito de clorhexidina en dispositivos de acceso venoso central no-tunelizados.


Siempre considere contraindicaciones


Referencias:

1. Griffith RJ, Jordan V, Herd D, Dalziel SR. Vapocoolants (cold spray) for pain treatment during intravenous cannulation. Cochrane Database Systematic Reviews. 2016, Issue 4. Art. No.CD009484.
2. Bugden S, Shean K, Scott M, et al. Skin glue reduces the failure rate of Emergency Department-inserted peripheral intravenous catheters: A randomized controlled trial. Annals of Emergency Medicine. 2016;68(2):196201.
3. Webster J, Osborne S, Rickard CM, New K. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database of Systematic Reviews. 2015, Issue 8. Art. No.: CD007798.
4. Mimoz O, Lucet J-C, Kerforne T, et al. Skin antisepsis with chlorhexidine alcohol versus povidone iodine alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. The Lancet. 2015;386(10008):206977.
5. Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, Mihala G, Rickard CM. Dressings and securement devices for central venous catheters (CVC). Cochrane Database of Systematic Reviews. 2015, Issue 9. Art. No.: CD010367.

Tags:AVATARIV managementvascular access devices

Address

Griffith University
Nathan
Queensland
Australia 4111